These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2442548)

  • 1. ACE inhibitors and the quality of life.
    Swales JD
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S22-5. PubMed ID: 2442548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antihypertensive agents on quality of life in the elderly.
    Fogari R; Zoppi A
    Drugs Aging; 2004; 21(6):377-93. PubMed ID: 15084140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
    Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
    Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
    Danilov SM; Tovsky SI; Schwartz DE; Dull RO
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of life and antihypertensive therapy].
    Vajó Z; Székács B
    Orv Hetil; 1993 Nov; 134(45):2477-9. PubMed ID: 7902554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors in the clinic: quality of life.
    Edmonds D; Vetter H; Vetter W
    J Hypertens Suppl; 1987 Aug; 5(3):S31-5. PubMed ID: 2889811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy for hypertension in the elderly.
    Kligman EW; Higbee MD
    J Fam Pract; 1989 Jan; 28(1):81-7. PubMed ID: 2563274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The issue of quality of life in antihypertensive therapy.
    Jern S; Zanchetti A
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S46-9. PubMed ID: 8487250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents.
    Schoenberger JA
    Am J Med; 1988 Apr; 84(4A):30-5. PubMed ID: 3064606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors and the progress of antihypertensive therapy.
    Julius S; Gupta R
    J Hypertens Suppl; 1989 Sep; 7(5):S23-7. PubMed ID: 2681602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of antihypertensive drug therapy on quality of life.
    Scherger JE
    Postgrad Med; 2000 Oct; 108(5 Suppl):25-9. PubMed ID: 19667538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
    Sica DA; Gehr TW; Fernandez A
    Drug Saf; 2000 May; 22(5):350-60. PubMed ID: 10830252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hospital intensive monitoring of adverse reactions of ACE inhibitors].
    Mangrella M; Motola G; Russo F; Mazzeo F; Giassa T; Falcone G; Rossi F; D'Alessio O; Rossi F
    Minerva Med; 1998 Apr; 89(4):91-7. PubMed ID: 9676174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Mancia G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertension in the elderly and its effects on the QOL].
    Mikami H
    Nihon Rinsho; 2005 Jun; 63(6):1096-100. PubMed ID: 15948397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
    Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
    Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.